Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis (Q59003574)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21561437%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21561437%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

main subject

visceral leishmaniasis

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21561437%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

V Ramesh

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21561437%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

G K Katara

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21561437%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

S Verma

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21561437%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

English

0 references

publication date

1 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21561437%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Dermatology

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21561437%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21561437%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

411-414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21561437%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21561437%20AND%20SRC:MED&resulttype=core&format=json

Post-kala-azar dermal leishmaniasis.

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10402.X

Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10402.X

Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10402.X

A simple and sensitive test for field diagnosis of post kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10402.X

Trial of oral miltefosine for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10402.X

Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10402.X

Leishmaniasis: drugs in the clinic, resistance and new developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10402.X

Development of miltefosine as an oral treatment for leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10402.X

Oral miltefosine in post-kala-azar dermal leishmaniasis--experience in three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10402.X

Immune response following miltefosine therapy in a patient with post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10402.X

Metabolism of ether phospholipids and analogs in neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10402.X

Treatment of leishmaniasis with miltefosine: 2008 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10402.X

10.1111/J.1365-2133.2011.10402.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21561437%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference